FEATURE STORY
● The Alliance for Regenerative Medicine outlines recommendations to increase the number of European-based ATMP clinical trials
GENE THERAPY
● Long-term correction of copper metabolism in WD mice with AAV8 vector delivering truncated ATP7b
● Enhancing the therapeutic potentiel of sulfamidase for the treatment of MPSIIIA
DISRUPTIVE TECHNOLOGIES
● Immunotherapy in HER2-positive breast cancer: state of the art and future perspectives.
CLINICAL TRIALS – DATAS
● FDA orders Novartis to hit the brakes on a Zolgensma® trial after animal study spurs safety concerns
● Arrowhead Pharmaceuticals presents preclinical data on ARO-ENaC at the North American Cystic Fibrosis Conference
M&A – AGREEMENTS
● Cognate BioServices announces acquisition of Cobra Biologics
● Dicerna enters agreement with Roche to develop and commercialize DCR-HBVS for the treatment of Chronic Hepatitis B Virus (HBV) infection
● Roivant, Sumitomo alliance to target cystic fibrosis gene therapy
● Vineti and WuXi AppTec Advanced Therapies collaborate to simplify manufacturing supply chain for Advanced Therapies
To read the full articles, click here: Trend Chart on Innovative BioIndustries November 7th
COMMENTS ARE OFF THIS POST